Chemotherapy readiness in pediatric oncology: Assessing an automated method to measure urine specific gravity.
| Autor: | Algiraigri AH; Department of Hematology, King Abdulaziz University Hospital, Jeddah, Saudi Arabia; King Faisal Special Hospital and Research Center, Jeddah, Saudi Arabia; Division of Pediatric Hematology and Oncology, Department of Pediatric, Alberta Children Hospital, Calgary, AB, Canada. Electronic address: aalgiraigri@kau.edu.sa., Truong TH; Division of Pediatric Hematology and Oncology, Department of Pediatric, Alberta Children Hospital, Calgary, AB, Canada., Lyon ME; University of Saskatchewan, Pathology and Laboratory Medicine, Saskatoon, SK, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2021 Jun; Vol. 14 (2), pp. 110-113. Date of Electronic Publication: 2020 May 21. |
| DOI: | 10.1016/j.hemonc.2020.04.008 |
| Abstrakt: | As part of the evaluation for chemotherapy readiness, urine specific gravity is measured to assess the patient's overall hydration status. Depending on the accuracy of the methods used, patients may be adversely affected by having their chemotherapy delayed or prematurely started. To evaluate the diagnostic accuracy of a new automated urine dipstick readout device (Clinitek), we tested 196 consecutive urine samples for urine specific gravity and compared them with the practical gold standard, a urine refractometer. We found a high correlation between both tools among clean urine samples, but a poor correlation among the pathological urine samples. (Copyright © 2020 King Faisal Specialist Hospital & Research Centre. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|